tirzepatide cardiovascular outcome trial Original Article: Outcomes with versus Dulaglutide in Type 2 Diabetes (SURPASS-CVOT trial) https://t.co/4BWhSd0ZCC #Endocrinology #Cardiology Tirzepatide for the Maintenance of

Baseline estimated renal function was normal (eGFR 90 mL/min/1.73m2) in 63.1%, mildly impaired (eGFR 60 to 90 mL/min/1.73m2) in 34.3%, and moderately impaired (eGFR 30 to 60 mL/min/1.73m2) in 2.5% of the patients

Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria

This is in keeping with the known association between obesity and T2D and psychiatric illness

Modern research emphasizes that BPC-157 is most effective when administered at pharmaceutical-grade purity under medical supervision to ensure proper dosing and monitoring

Ipamorelin is a GHSR agonist that acts through the ghrelin receptor pathway

Medical Reviewer Dr